JBT Marel (JBTM) Q3 2024 earnings summary

Executive summary

• Achieved record Q3 2024 results with 12.4% year-over-year revenue growth, significant margin expansion, and strong order intake, driven by demand recovery in global poultry and diverse end markets.

• Orders totaled $440 million, up 10% year-over-year, with backlog near $700 million and notable strength in poultry, pet food, fruit and vegetable, pharma, and warehouse automation.

• AGV (automated guided vehicle) business exceeded $150 million in revenue, growing over 30% year-over-year, with margins above 20%.

• Integration planning for the Marel merger is progressing, with regulatory approvals nearing completion and financing secured; expected to close by year-end 2024.

• Strategic focus remains on organic growth, digital transformation, margin enhancement, and acquisitions under the Elevate 2.0 strategy.

Financial highlights

• Q3 2024 revenue reached $454 million, up 12.4% year-over-year; gross profit margin improved to 36.1%.

• Adjusted EBITDA was $82 million, up 23% year-over-year, with margin at 18% (up 160 basis points).

• Adjusted EPS was $1.50, up 35% year-over-year; GAAP EPS was $1.18, up 22%.

• Year-to-date free cash flow was $79 million; trailing twelve-month free cash flow was $184 million.

• Net income from continuing operations was $38.1 million, up 23% year-over-year.

Outlook and guidance

• Reiterated full-year 2024 guidance: revenue $1,715–$1,750 million, adjusted EBITDA $295–$305 million, adjusted EPS $5.05–$5.35.

• Expects 3%-5% revenue growth and 10% Adjusted EBITDA growth for 2024.

• Updated GAAP EPS guidance to $3.60–$3.90 and income from continuing operations to $116–$125 million, reflecting pension plan settlement charges.

• Pension plan settlement expected to result in $28–$32 million non-cash pre-tax expense in Q4 2024, with remaining loss recognized in early 2025.

• Free cash flow conversion rate anticipated above 100% for the full year.